Y-Intercept (HK)’s Cytokinetics CYTK Stock Holding History

Y-Intercept (HK)’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.72M	Buy	+43,619	New	+$3.13M	0.07%	384
2026 Q1	–	Sell	-5,790	Closed	-$368K	–	1647
2025 Q4	$368K	Sell	5,790 -18,942	-77%	-$1.18M	0.01%	1319
2025 Q3	$1.36M	Buy	+24,732	New	+$1.02M	0.03%	823
2024 Q1	–	Sell	-33,215	Closed	-$2.77M	–	1438
2023 Q4	$2.77M	Buy	+33,215	New	+$1.2M	0.26%	78
2022 Q3	–	Sell	-12,270	Closed	-$482K	–	1025
2022 Q2	$482K	Buy	+12,270	New	+$494K	0.06%	439

Other funds holding CYTK

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Y-Intercept (HK)'s CYTK Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Cytokinetics (CYTK) in Q2 2026: 43,619 shares worth $3.72M. The stake represents 0.07% of the portfolio and ranks #384 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in CYTK as recently as Q4 2025.

Y-Intercept (HK) first reported a position in CYTK in Q2 2022 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Y-Intercept (HK) held 43,619 shares of Cytokinetics worth $3.72M as of Q2 2026.
Cytokinetics was a new Y-Intercept (HK) position in Q2 2026.
Cytokinetics made up 0.07% of Y-Intercept (HK)'s portfolio in Q2 2026, its #384 holding.
Y-Intercept (HK) first reported a position in Cytokinetics in Q2 2022 and has held it in 5 quarters since.
51 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.